Sökning: onr:"swepub:oai:gup.ub.gu.se/219674" >
Beta-blocker Use an...
Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure
-
Bhatia, V. (författare)
-
Bajaj, N. S. (författare)
-
Sanam, K. (författare)
-
visa fler...
-
Hashim, T. (författare)
-
Morgan, C. J. (författare)
-
Prabhu, S. D. (författare)
-
Fonarow, G. C. (författare)
-
Deedwania, P. (författare)
-
Butler, J. (författare)
-
Carson, P. (författare)
-
Love, T. E. (författare)
-
Kheirbek, R. (författare)
-
Aronow, W. S. (författare)
-
Anker, S. D. (författare)
-
- Waagstein, Finn, 1938 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för medicin,Institute of Medicine
-
Fletcher, R. (författare)
-
Allman, R. M. (författare)
-
Ahmed, A. (författare)
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2015
- 2015
- Engelska.
-
Ingår i: American Journal of Medicine. - : Elsevier BV. - 0002-9343. ; 128:7, s. 715-721
- Relaterad länk:
-
https://europepmc.or...
-
visa fler...
-
https://gup.ub.gu.se...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- BACKGROUND: Beta-blockers improve outcomes in patients with systolic heart failure. However, it is unknown whether their initial negative inotropic effect may increase 30-day all-cause readmission, a target outcome for Medicare cost reduction and financial penalty for hospitals under the Affordable Care Act. METHODS: Of the 3067 Medicare beneficiaries discharged alive from 106 Alabama hospitals (1998-2001) with a primary discharge diagnosis of heart failure and ejection fraction <45%, 2202 were not previously on beta-blocker therapy, of which 383 received new discharge prescriptions for beta-blockers. Propensity scores for beta-blocker use, estimated for each of the 2202 patients, were used to assemble a matched cohort of 380 pairs of patients receiving and not receiving beta-blockers who were balanced on 36 baseline characteristics (mean age 73 years, mean ejection fraction 27%, 45% women, 33% African American). RESULTS: Beta-blocker use was not associated with 30-day all-cause readmission (hazard ratio [HR] 0.87; 95% confidence interval [CI], 0.64-1.18) or heart failure readmission (HR 0.95; 95% CI, 0.57-1.58), but was significantly associated with lower 30-day all-cause mortality (HR 0.29; 95% CI, 0.12-0.73). During 4-year postdischarge, those in the beta-blocker group had lower mortality (HR 0.81; 95% CI, 0.67-0.98) and combined outcome of all-cause mortality or all-cause readmission (HR 0.87; 95% CI, 0.74-0.97), but not with all-cause readmission (HR 0.89; 95% CI, 0.76-1.04). CONCLUSIONS: Among hospitalized older patients with systolic heart failure, discharge prescription of beta-blockers was associated with lower 30-day all-cause mortality and 4-year combined death or readmission outcomes without higher 30-day readmission. Published by Elsevier Inc.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Nyckelord
- Beta-blockers
- Hospitalization
- Older adults
- Readmission
- Systolic heart failure
- CONVERTING ENZYME-INHIBITORS
- RENIN-ANGIOTENSIN INHIBITION
- PRESERVED
- EJECTION FRACTION
- CHRONIC KIDNEY-DISEASE
- ATRIAL-FIBRILLATION
- TRIAL
- MORTALITY
- THERAPY
- CARVEDILOL
- PROGRAM
- Medicine
- General & Internal
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas
- Av författaren/redakt...
-
Bhatia, V.
-
Bajaj, N. S.
-
Sanam, K.
-
Hashim, T.
-
Morgan, C. J.
-
Prabhu, S. D.
-
visa fler...
-
Fonarow, G. C.
-
Deedwania, P.
-
Butler, J.
-
Carson, P.
-
Love, T. E.
-
Kheirbek, R.
-
Aronow, W. S.
-
Anker, S. D.
-
Waagstein, Finn, ...
-
Fletcher, R.
-
Allman, R. M.
-
Ahmed, A.
-
visa färre...
- Om ämnet
-
- MEDICIN OCH HÄLSOVETENSKAP
-
MEDICIN OCH HÄLS ...
-
och Klinisk medicin
-
och Kardiologi
- Artiklar i publikationen
-
American Journal ...
- Av lärosätet
-
Göteborgs universitet